Towards Precision Radiation Oncology: Endocrine Therapy Resistance as a Biomarker for Radiation Resistance in ER-Positive Breast Cancer

被引：0
|
作者：
Udden, S. M. Nashir
Rahimi, Asal
Kim, Dong W. Nathan
Alluri, Prasanna
机构：
来源：
CANCER RESEARCH | 2023年 / 83卷 / 05期
关键词：
D O I：
10.1158/1538-7445.SABCS22-P4-02-08
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P4-02-08
引用
下载
收藏
页数：2
相关论文
共 50 条
  • [1] Towards precision radiation oncology: endocrine therapy response as a biomarker for personalization of breast radiotherapy
    S. M. Nashir Udden
    GuemHee Baek
    Kamal Pandey
    Chantal Vidal
    Yulun Liu
    Asal S. Rahimi
    D. Nathan Kim
    Chika R. Nwachukwu
    Ram S. Mani
    Prasanna G. Alluri
    npj Precision Oncology, 7
  • [2] Towards precision radiation oncology: endocrine therapy response as a biomarker for personalization of breast radiotherapy
    Udden, S. M. Nashir
    Baek, GuemHee
    Pandey, Kamal
    Vidal, Chantal
    Liu, Yulun
    Rahimi, Asal S.
    Kim, D. Nathan
    Nwachukwu, Chika R.
    Mani, Ram S.
    Alluri, Prasanna G.
    NPJ PRECISION ONCOLOGY, 2023, 7 (01)
  • [3] The role of ELF3 in acquired resistance to endocrine therapy in ER-positive breast cancer
    Zhang, Na
    Zheng, Rongbin
    Brown, Myles
    CANCER RESEARCH, 2023, 83 (07)
  • [4] ER-positive breast cancer cells are poised for RET-mediated endocrine resistance
    Horibata, Sachi
    Rice, Edward J.
    Mukai, Chinatsu
    Marks, Brooke A.
    Sams, Kelly
    Zheng, Hui
    Anguish, Lynne J.
    Coonrod, Scott A.
    Danko, Charles G.
    PLOS ONE, 2018, 13 (04):
  • [5] Endocrine therapy resistance in estrogen receptor (ER)-positive breast cancer
    De Marchi, Tommaso
    Foekens, John A.
    Umar, Arzu
    Martens, John W. M.
    DRUG DISCOVERY TODAY, 2016, 21 (07) : 1181 - 1188
  • [6] ER and PI3K Independently Modulate Endocrine Resistance in ER-Positive Breast Cancer
    Van Tine, Brian A.
    Crowder, Robert J.
    Ellis, Matthew J.
    CANCER DISCOVERY, 2011, 1 (04) : 287 - 288
  • [7] Biomarker alterations in ER-positive breast cancer patients who undertook neoadjuvant endocrine therapy
    Hayama, S.
    Nakamura, R.
    Sangai, T.
    Nagashima, T.
    Ohtsuka, M.
    Yamamoto, N.
    BREAST, 2017, 32 : S79 - S79
  • [8] Aberrant Regulation of RAD51 Promotes Resistance of Neoadjuvant Endocrine Therapy in ER-positive Breast Cancer
    Yan Jia
    Yueshuai Song
    Guolei Dong
    Chunfang Hao
    Weipeng Zhao
    Shufen Li
    Zhongsheng Tong
    Scientific Reports, 9
  • [9] Aberrant Regulation of RAD51 Promotes Resistance of Neoadjuvant Endocrine Therapy in ER-positive Breast Cancer
    Jia, Yan
    Song, Yueshuai
    Dong, Guolei
    Hao, Chunfang
    Zhao, Weipeng
    Li, Shufen
    Tong, Zhongsheng
    SCIENTIFIC REPORTS, 2019, 9 (1)
  • [10] ESR1 Mutation Status as a Biomarker for Radiation Response in ER-Positive Breast Cancer
    Udden, N.
    Wang, Q.
    Alluri, P. G.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (03): : E35 - E36
12345